Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science Times Observer.
Press releases published on May 14, 2025
Biomea Fusion’s BMF-500 Selected for Poster Presentation at EHA 2025 Highlighting Phase I Data in Relapsed/Refractory Acute Leukemia
GlobeNewswire
·
May 14, 2025
REDWOOD CITY, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity medicines company, today announced that preliminary clinical data from the Phase I COVALENT-103 trial of BMF-500 in …
Snail, Inc. Reports First Quarter 2025 Financial Results
GlobeNewswire
·
May 14, 2025
CULVER CITY, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- Snail, Inc. (Nasdaq: SNAL) (“Snail Games” or the “Company”), a leading global independent developer and publisher of interactive digital entertainment, today announced financial results for its first …
dLocal Reports 2025 First Quarter Financial Results
GlobeNewswire
·
May 14, 2025
Record highs across key financial and operational metrics. TPV milestone of US$8 billion, +53% YoY and +5% QoQ. In constant currency, TPV increased +72% YoY. Revenue and gross profit record highs of US$217 million and US$85 million. Continued geographic …
Inhibikase Therapeutics Announces First Quarter 2025 Financial Results and Highlights Recent Activity
GlobeNewswire
·
May 14, 2025
BOSTON and ATLANTA, May 14, 2025 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company innovating small molecule kinase inhibitor therapeutics to treat pulmonary arterial …
Journey Medical Corporation Reports First Quarter 2025 Financial Results and Recent Corporate Highlights
GlobeNewswire
·
May 14, 2025
Revenue for the First Quarter Ended March 31, 2025 was $13.1 million Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules) Commercial Launch Off to a Strong Start, Initial Prescriptions Filled in Late March 2025 Phase 3 Clinical Trial Results …
scPharmaceuticals Inc. Reports First Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
May 14, 2025
Generated net FUROSCIX® revenue of $11.8 million in the first quarter of 2025 Formally launched FUROSCIX in second approved indication, Chronic Kidney Disease, in April 2025 Autoinjector on track for sNDA submission in Q3 2025; designed to reduce treatment …
Galapagos kondigt mondelinge presentaties aan tijdens EHA en ICML 2025 met veelbelovende nieuwe resultaten uit de ATALANTA-1 studie met CAR-T kandidaat GLPG5101
GlobeNewswire
·
May 14, 2025
Mechelen, België; 14 mei 2025, 22:01 CET; Galapagos NV (Euronext …
Galapagos Announces Oral Presentations at EHA and ICML 2025 Featuring Promising New Data from ATALANTA-1 study of Investigational CAR-T Candidate GLPG5101
GlobeNewswire
·
May 14, 2025
Mechelen, Belgium; May 14, 2025, 22:01 CET; Galapagos NV (Euronext …
Nkarta Reports First Quarter 2025 Financial Results and Corporate Highlights
GlobeNewswire
·
May 14, 2025
Enrollment open in investigator-sponsored trial (IST) of NKX019 in myasthenia gravis; Ntrust-1, Ntrust-2, and IST of NKX019 in systemic lupus erythematosus remain open to enrollment Ntrust-1 expanded to include primary membranous nephropathy cohort …
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
May 14, 2025
PALO ALTO, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, today announced that on May 9, 2025, the compensation committee …
Denver Post Names Biodesix a Winner of Top Workplaces 2025 Award
GlobeNewswire
·
May 14, 2025
LOUISVILLE, Colo., May 14, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company, is pleased to announce that it is a Colorado Top Workplaces 2025 Winner. The Top Workplaces program has an 18-year history of …
Maze Therapeutics Reports First Quarter 2025 Financial Results and Reiterates Upcoming Milestones
GlobeNewswire
·
May 14, 2025
MZE829 Phase 2 HORIZON Trial Enrolling Patients with APOL1 Kidney Disease; Initial Data Expected in Q1 2026 MZE782 Phase 1 Healthy Volunteer Trial Ongoing; Initial Data Expected in Q3 2025 Strong Balance Sheet with $294.4 Million in Cash and Cash …
Xenon to Present at the 2025 RBC Capital Markets Global Healthcare Conference
GlobeNewswire
·
May 14, 2025
VANCOUVER, British Columbia and BOSTON, May 14, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics for …
Eledon Pharmaceuticals Reports First Quarter 2025 Operating and Financial Results
GlobeNewswire
·
May 14, 2025
On track to report topline results from Phase 2 BESTOW trial in kidney transplantation in fourth quarter of 2025 Tegoprubart used as a key component of immunosuppression regimen in its second transplant of a genetically modified pig kidney into a human …
MDxHealth Reports Q1-2025 Results
GlobeNewswire
·
May 14, 2025
Year-over-year Q1 revenues increase by 22% to $24.3 million 71% year-over-year improvement in adjusted EBITDA in first quarter Conference call with Q…
Hawkins, Inc. Declares Quarterly Cash Dividend of $0.18 Per Share
GlobeNewswire
·
May 14, 2025
ROSEVILLE, Minn., May 14, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of Hawkins, Inc. (Nasdaq: HWKN), at its meeting on May 14, 2025, declared a quarterly cash dividend of $0.18 per share, payable June 13, 2025, to shareholders of record at the close …
Goldfinch, Digital Genesis Launch $20 Million Web3 and AI Entertainment Venture at Cannes
GlobeNewswire
·
May 14, 2025
Cannes, May 14, 2025 (GLOBE NEWSWIRE) -- CANNES, 17th May 2025 – On the sidelines of the 2025 Cannes Film Festival, veteran producer and film financier Goldfinch Holdings (UK) and the newly established, soon-to-be-public Digital Genesis Fund (Luxembourg) …
Vassal Benford & Mally Mall: The Hitmakers Redefining the Sound of a Generation
GlobeNewswire
·
May 14, 2025
Beverly Hills, CA, May 14, 2025 (GLOBE NEWSWIRE) -- When you think platinum plaques, Grammy wins, and genre-defying anthems, two names consistently rise to the top: Vassal Benford and Mally Mall. These musical visionaries have long been individually …
Red Cat Reports Financial Results for First Quarter 2025 and Provides Corporate Update
GlobeNewswire
·
May 14, 2025
SAN JUAN, Puerto Rico, May 14, 2025 (GLOBE NEWSWIRE) -- Red Cat Holdings, Inc. (Nasdaq: RCAT) ("Red Cat" or the "Company"), a drone technology company integrating robotic hardware and software for military, government, and commercial operations, reports …
CapitalRevo Reveals Powerful AI-Driven Features Ushering in a New Era of Smart Trading
GlobeNewswire
·
May 14, 2025
CapitalRevo has launched a powerful suite of AI-driven features aimed at transforming the trading experience for users of all levels. The platform now offers real-time market insights, emotion-free decision-making, and adaptive, self-learning algorithms to …